5-HT 6 receptor agonists (Carlsson/Merck KGaA)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT 6 receptor agonists (Carlsson/Merck KGaA)
Drug Alias Nameantidepressants (Merck KGaA/Carlsson)schizophrenia therapy (Merck KGaA/Carlsson)antipsychotics (Merck KGaA/Carlsson)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor agonists
TargetsSerotonin 6 (5-HT6) receptor
Therapy Area/IndicationsSchizophreniaDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, Germany
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck KGaA, Darmstadt, GermanyA. Carlsson Research Ab
Active IndicationsN/A
Inactive IndicationsSchizophreniaDepression

Other Information

ATC CodeN/A
Related LinksN/A